The Taking Cancer on Podcast Homepage
In an effort to simplify the science behind our ambition to ‘drug the undruggable’, this podcast draws back the curtain on cancer research and takes a look at its complex inner workings. Hosted by Sebastian Hermelin (co-founder of the War On Cancer app), each episode welcomes a new expert guest who takes the listener through one of the many stages of cancer research and drug development; from early discovery efforts, through to clinical trials and drug approval.
Our currently available episodes are listed below, but stay tuned, more episodes will be coming soon…
Episode 5: Keith’s Journey With Lung Cancer
Expert Guests: Keith Perry, lung cancer survivor Listen on: Apple Podcasts, Spotify, Deezer, Amazon Music
In episode 5, we turn our attention to living with lung cancer. Sebastian speaks to Keith Perry, a lung cancer survivor who took a truly awe-inspiring approach to his recovery journey after losing his left lung to cancer. Disclaimer: This episode reflects the unique experiences of an individual living with lung cancer. The experiences of other people living with lung cancer will vary.
You can subscribe to the series on Apple Podcast, Spotify or Deezer to stay up to date on Taking Cancer On.
In this episode we cover:
[00:54] Keith’s diagnosis, treatment and recovery journey
[19:44] Not your typical lung cancer patient
[22:15] Cancer conversations
[27:14] Support systems
[32:23] In closing
Episode 4: Helping the Immune System to Take Cancer On
Expert Guests: Jose Barrueco Ph.D. and Petra Blum M.D., both leading Global Clinical Development teams in Oncology at Boehringer Ingelheim.
In this episode, Jose and Petra discuss cancer immunology and explain what it takes to develop cancer immunotherapies. How can the immune system be used to treat cancer? What is Boehringer Ingelheim contributing to this field? What is the future of cancer immunotherapy? Listen to this episode to find out more!
In this episode we cover:
[00:43] What is cancer immunology and immunotherapy?
[13:41] Cancer immunology at Boehringer Ingelheim
[20:50] The future of cancer immunotherapies
Episode 3: Collaborating Against Cancer
Expert Guests: Dr Scott DeWire, Head of US Business Development at Boehringer Ingelheim and Dr Andrew Fadden, Head of Corporate Development at Enara Bio about the power of research partnerships in progressing cancer innovation and drug development.
What do pharmaceutical partnerships entail? What can we gain from collaborating with partners? Do we share the same goals? Listen to this episode to find out more!
In this episode, we hear from Dr Scott DeWire, Head of US Business Development at Boehringer Ingelheim (BI) and Dr Andrew Fadden, Head of Corporate Development at Enara Bio about the power of research partnerships in progressing cancer innovation and drug development. Their discussion proves that embracing collaboration is essential in delivering ground-breaking treatments to patients, faster.
In this episode we cover:
[4:16] Boehringer Ingelheim & Enara Bio partnership
[14:57] Importance of patients in pharmaceutical partnerships
[21:14] Pharmaceutical partnerships in general
[24:43] Boehringer Ingelheim & Enara Bio's partnering philosophy
Episode 2: Under the Surface of Clinical Trials
Expert Guests: Dr Victoria Zazulina, Corporate Vice President and Global Head of Oncology Medicine at Boehringer Ingelheim and Ivy Elkins, lung cancer survivor and advocate and co-founder of the EGFR resisters patient group.
What are the benefits, barriers, risks and rewards of taking part in a cancer trial? Do physicians and patients see things in the same light?
In this episode, our host Sebastian discusses all things clinical with those who have deep insight from personal experience: Ivy Elkins, co-Founder of EGFR-Resisters, a lung cancer survivor herself and a cancer advocate as well as Dr Victoria Zazulina, Corporate Vice President and Global Head of Oncology Medicine at Boehringer Ingelheim. Listen-in!
In this episode we cover:
[7:06] What is a clinical trial?
[08:25] Patient benefits of participating in a clinical trial
[11:51] The challenges of trial recruitment
[16:23] The gap between the research and patient communities
[23.11] The impacts of the COVID-19 pandemic
Episode 1: Taking On The Beating Heart of Cancer
Expert Guest: Dr Darryl McConnell, Senior Vice President and Research Site Head for Boehringer Ingelheim, Austria
A breakthrough in KRAS research could mean improved treatment options for 1 in 7 cancer patients across the globe. With stats like that in mind, it’s easy to see why Dr Darryl McConnell is fascinated (some might even say obsessed) with KRAS-driven cancers, despite them being considered ‘undruggable’ for many decades.
In this episode we explore the very beginnings of cancer research. The discovery of drug candidates for new therapeutic concepts is the first key stepping-stone towards getting treatments to the patients who need them most.
Additional Information
Related Content
